Cellectis SA (CLLS)
3.19
-0.16
(-4.78%)
USD |
NASDAQ |
Sep 01, 15:48
Cellectis Total Long Term Debt (Quarterly) : 96.78M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.78M |
| March 31, 2026 | 99.70M |
| December 31, 2025 | 109.44M |
| September 30, 2025 | 100.98M |
| June 30, 2025 | 95.60M |
| March 31, 2025 | 92.04M |
| December 31, 2024 | 93.51M |
| September 30, 2024 | 106.77M |
| June 30, 2024 | 105.07M |
| March 31, 2024 | 99.01M |
| December 31, 2023 | 87.69M |
| September 30, 2023 | 95.27M |
| June 30, 2023 | 94.70M |
| March 31, 2023 | 76.09M |
| December 31, 2022 | 70.80M |
| September 30, 2022 | 86.26M |
| June 30, 2022 | 90.32M |
| March 31, 2022 | 96.49M |
| December 31, 2021 | 98.62M |
| September 30, 2021 | 104.58M |
| June 30, 2021 | 106.93M |
| March 31, 2021 | 108.37M |
| December 31, 2020 | 106.68M |
| Date | Value |
|---|---|
| September 30, 2020 | 103.16M |
| June 30, 2020 | 75.28M |
| March 31, 2020 | 50.04M |
| December 31, 2019 | 47.61M |
| September 30, 2019 | 47.46M |
| June 30, 2019 | 47.81M |
| March 31, 2019 | 35.65M |
| December 31, 2018 | 1.351M |
| September 30, 2018 | 0.288M |
| June 30, 2018 | 0.31M |
| March 31, 2018 | 0.347M |
| December 31, 2017 | 0.034M |
| September 30, 2017 | 0.0442M |
| June 30, 2017 | 0.0536M |
| March 31, 2017 | 0.0589M |
| December 31, 2016 | 0.0675M |
| September 30, 2016 | 0.0809M |
| June 30, 2016 | 0.0989M |
| March 31, 2016 | 0.1277M |
| December 31, 2015 | 2.158M |
| September 30, 2015 | 0.0826M |
| June 30, 2015 | 0.2986M |
| March 31, 2015 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| DBV Technologies SA | 5.10M |
| Akari Therapeutics Plc | 0.00 |
| EDAP TMS SA | 39.00M |
| Autolus Therapeutics Plc | 362.02M |
| Evaxion AS | 7.105M |